EV/EBITDA
-2.11
-0.03-1.44%
Fri, 29 Nov 2024 21:04:30 GMT
Summary:
Nektar Therapeutics EV/EBITDA is currently -2.11, with a fall of -0.03 (-1.44%) during the most recent trading day. Over the past year, it has dropped by -1.56 (-283.64%). NKTR EV/EBITDA is now -100.71% below its all-time high of 297.90.NKTR EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -1.4% |
1 m1 month | +10.2% |
3 m3 months | +3.2% |
6 m6 months | +6.6% |
ytdytd | -163.8% |
1 y1 year | -283.6% |
5 y5 years | +79.9% |
NKTR EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -1.91 | -10.5% | -2.48 | +14.9% |
3 m | 3 months | -1.91 | -10.5% | -2.55 | +17.3% |
6 m | 6 months | -1.79 | -17.9% | -2.55 | +17.3% |
1 y | 1 year | -0.55 | -283.6% | -2.82 | +25.2% |
3 y | 3 years | -0.41 | -414.6% | -6.91 | +69.5% |
5 y | 5 years | -0.41 | -414.6% | -13.79 | +84.7% |
alltime | all time | 297.90 | -100.7% | -2023 | +99.9% |
Nektar Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -2.11(+163.8%) |
2023 | -0.80(-44.8%) |
2022 | -1.45(-74.5%) |
2021 | -5.68(-25.9%) |
2020 | -7.67(-29.2%) |
2019 | -10.83(-238.5%) |
2018 | 7.82(-103.2%) |
2017 | -241.88(+1014.7%) |
2016 | -21.70(-74.6%) |
2015 | -85.48(-89.1%) |
2014 | -785.11(+5689.9%) |
2013 | -13.56(+73.4%) |
2012 | -7.82(-1.5%) |
2011 | -7.94(-94.8%) |
2010 | -153.10(+1000.6%) |
Date | Value |
---|---|
2009 | -13.91(-105.9%) |
2008 | 233.84(-289.3%) |
2007 | -123.55(+781.2%) |
2006 | -14.02(+28.5%) |
2005 | -10.91(-68.1%) |
2004 | -34.18(+49.3%) |
2003 | -22.90(+148.9%) |
2002 | -9.20(-40.8%) |
2001 | -15.53(-61.5%) |
2000 | -40.36(+51.6%) |
1999 | -26.62(+8.0%) |
1998 | -24.64(-14.4%) |
1997 | -28.80(+107.8%) |
1996 | -13.86(+27.5%) |
1995 | -10.87(-13.4%) |
1994 | -12.55 |
FAQ
- What is Nektar Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Nektar Therapeutics?
- What is NKTR EV/EBITDA year-to-date change?
- What is Nektar Therapeutics EV/EBITDA year-on-year change?
What is Nektar Therapeutics EV/EBITDA?
The current EV/EBITDA of NKTR is -2.11
What is the all time high EV/EBITDA for Nektar Therapeutics?
Nektar Therapeutics all-time high EV/EBITDA is 297.90
What is NKTR EV/EBITDA year-to-date change?
Nektar Therapeutics EV/EBITDA has changed by -1.31 (-163.75%) since the beginning of the year
What is Nektar Therapeutics EV/EBITDA year-on-year change?
Over the past year, NKTR EV/EBITDA has changed by -1.56 (-283.64%)